dehydroepiandrosterone has been researched along with Bladder Cancer in 5 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Excerpt | Relevance | Reference |
---|---|---|
"The risk of developing bladder cancer increased monotonically with decreasing serum levels of both steroids." | 5.28 | Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer. ( Comstock, GW; Gordon, GB; Helzlsouer, KJ, 1991) |
"The risk of developing bladder cancer increased monotonically with decreasing serum levels of both steroids." | 1.28 | Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer. ( Comstock, GW; Gordon, GB; Helzlsouer, KJ, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Neuzillet, Y | 1 |
Raynaud, JP | 1 |
Radulescu, C | 1 |
Fiet, J | 1 |
Giton, F | 1 |
Dreyfus, JF | 1 |
Ghoneim, TP | 1 |
Lebret, T | 1 |
Botto, H | 1 |
Shibata, MA | 1 |
Shirai, T | 1 |
Asakawa, E | 1 |
Hirose, M | 1 |
Fukushima, S | 1 |
Orner, GA | 1 |
Hendricks, JD | 1 |
Arbogast, D | 1 |
Williams, DE | 1 |
Gordon, GB | 1 |
Helzlsouer, KJ | 1 |
Comstock, GW | 1 |
Moore, MA | 1 |
Thamavit, W | 1 |
Tsuda, H | 1 |
Sato, K | 1 |
Ichihara, A | 1 |
Ito, N | 1 |
5 other studies available for dehydroepiandrosterone and Bladder Cancer
Article | Year |
---|---|
Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial).
Topics: Aged; Androstenediol; Body Mass Index; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihyd | 2017 |
Inhibition by dehydroepiandrosterone of butylated hydroxyanisole (BHA) promotion of rat-bladder carcinogenesis and enhancement of BHA-induced forestomach hyperplasia.
Topics: Animals; Body Weight; Butylated Hydroxyanisole; Dehydroepiandrosterone; DNA; Drug Synergism; Hyperpl | 1993 |
Modulation of N-methyl-N'-nitro-nitrosoguanidine multiorgan carcinogenesis by dehydroepiandrosterone in rainbow trout.
Topics: Animals; Carcinogens; Dehydroepiandrosterone; Kidney Neoplasms; Liver Neoplasms, Experimental; Methy | 1996 |
Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer.
Topics: Aged; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Male; Middle Aged; Ris | 1991 |
Modifying influence of dehydroepiandrosterone on the development of dihydroxy-di-n-propylnitrosamine-initiated lesions in the thyroid, lung and liver of F344 rats.
Topics: Animals; Body Weight; Carcinogens; Dehydroepiandrosterone; gamma-Glutamyltransferase; Glucosephospha | 1986 |